These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26930407)

  • 1. Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
    Tsuneyama N; Suzuki Y; Sawamura K; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
    PLoS One; 2016; 11(3):e0149518. PubMed ID: 26930407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.
    Hosojima H; Togo T; Odawara T; Hasegawa K; Miura S; Kato Y; Kanai A; Kase A; Uchikado H; Hirayasu Y
    J Psychopharmacol; 2006 Jan; 20(1):75-9. PubMed ID: 16204328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased food intake and energy expenditure following administration of olanzapine to healthy men.
    Fountaine RJ; Taylor AE; Mancuso JP; Greenway FL; Byerley LO; Smith SR; Most MM; Fryburg DA
    Obesity (Silver Spring); 2010 Aug; 18(8):1646-51. PubMed ID: 20134408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain.
    Atmaca M; Tezcan E; Ustundag B
    J Psychiatr Res; 2007; 41(1-2):74-9. PubMed ID: 16426639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin.
    Lu ML; Wang TN; Lin TY; Shao WC; Chang SH; Chou JY; Ho YF; Liao YT; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():47-50. PubMed ID: 25496829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia.
    Baptista T; Dávila A; El Fakih Y; Uzcátegui E; Rangel NN; Olivares Y; Galeazzi T; Vargas D; Peña R; Marquina D; Villarroel V; Teneud L; Beaulieu S
    Int Clin Psychopharmacol; 2007 Jul; 22(4):205-11. PubMed ID: 17519643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
    Perez-Iglesias R; Vazquez-Barquero JL; Amado JA; Berja A; Garcia-Unzueta MT; Pelayo-Terán JM; Carrasco-Marín E; Mata I; Crespo-Facorro B
    J Clin Psychopharmacol; 2008 Jun; 28(3):289-95. PubMed ID: 18480685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.
    Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol.
    Raposo NR; Ferreira AS; Gattaz WF
    Pharmacopsychiatry; 2011 Jul; 44(5):169-72. PubMed ID: 21732272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.
    Lin Y; Peng Y; He S; Xu J; Shi Y; Su Y; Zhu C; Zhang X; Zhou R; Cui D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):71-78. PubMed ID: 29410009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine increases plasma ghrelin level in patients with schizophrenia.
    Murashita M; Kusumi I; Inoue T; Takahashi Y; Hosoda H; Kangawa K; Koyama T
    Psychoneuroendocrinology; 2005 Jan; 30(1):106-10. PubMed ID: 15358448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia.
    Bushe C; Sniadecki J; Bradley AJ; Poole Hoffmann V
    J Psychopharmacol; 2010 Jul; 24(7):1001-9. PubMed ID: 19240085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.
    Cortés B; Bécker J; Mories Álvarez MT; Marcos AI; Molina V
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):127-32. PubMed ID: 24552633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia.
    Sugai T; Suzuki Y; Fukui N; Ono S; Watanabe J; Tsuneyama N; Someya T
    J Clin Psychopharmacol; 2012 Jun; 32(3):390-3. PubMed ID: 22544005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid leptin elevation after initiation of olanzapine?
    Wang HC; Chen PS; Lee IH; Yang YK; Yeh TL; Lu RB
    Neuropsychobiology; 2006; 54(3):182-5. PubMed ID: 17314489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
    Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
    Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.
    Ellingrod VL; Bishop JR; Moline J; Lin YC; Miller DD
    Psychopharmacol Bull; 2007; 40(1):57-62. PubMed ID: 17285096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.